No abstract available
Keywords:
Avelumab; JAVELIN; bladder cancer; maintenance; urothelial carcinoma (UC).
PubMed Disclaimer
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-24-16/coif). The authors have no conflicts of interest to declare.
Comment on
-
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance.
Sridhar SS, Powles T, Climent Durán MÁ, Park SH, Massari F, Thiery-Vuillemin A, Valderrama BP, Ullén A, Tsuchiya N, Aragon-Ching JB, Gupta S, Petrylak DP, Bellmunt J, Wang J, Laliberte RJ, di Pietro A, Costa N, Grivas P, Sternberg CN, Loriot Y.
Sridhar SS, et al.
Eur Urol. 2024 Feb;85(2):154-163. doi: 10.1016/j.eururo.2023.08.001. Epub 2023 Sep 14.
Eur Urol. 2024.
PMID: 37714742
Clinical Trial.
References
-
-
Powles T, Park SH, Voog E, et al. Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma. N Engl J Med 2020;383:1218-30. 10.1056/NEJMoa2002788
-
DOI
-
PubMed
-
-
Grivas P, Park SH, Voog E, et al. Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial. Eur Urol 2023;84:95-108. 10.1016/j.eururo.2023.03.030
-
DOI
-
PubMed
-
-
Sonpavde GP, Mariani L, Lo Vullo S, et al. Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma. J Urol 2018;200:1207-14. 10.1016/j.juro.2018.07.035
-
DOI
-
PMC
-
PubMed
-
-
Grivas P, Agarwal N, Pal S, et al. Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice. Cancer Treat Rev 2021;97:102187. 10.1016/j.ctrv.2021.102187
-
DOI
-
PubMed
-
-
Sridhar SS, Powles T, Climent Durán MÁ, et al. Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance. Eur Urol 2024;85:154-63. 10.1016/j.eururo.2023.08.001
-
DOI
-
PubMed